Palavras-chave
embarazo
plasmaféresis
inmunidad humoral
corticoesteroides
Como Citar
Resumo
La neuromielitis óptica (NMO) es una enfermedad inflamatoria autoinmune desmielinizante del sistema nervioso central, mediada por autoanticuerpos contra el receptor de acuaporina 4 (Ac IgQ4). Se presenta el caso de una mujer de 23 años de edad con 28 semanas de embarazo y antecedente de neuromielitis óptica, quien consultó por recaída de la enfermedad y pobre respuesta al manejo con corticosteroides, por lo que recibió 5 sesiones de plasmaféresis y tuvo una importante mejoría clínica.
Shang W, Liu J. Neuromyelitis optica during pregnancy. Int J Gynaecol Obstet [Internet]. 2011 Oct [cited 2013 Mar 28];115(1):66-8. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/21782174.
Kim W, Kim S-H, Nakashima I, Takai Y, Fujihara K, Leite MI, et al. Influence of pregnancy on neuromyelitis optica spectrum disorder. Neurology. 2012 Apr;78(16):1264-7.
Lucchinetti CF, Mandler R N, McGavern D, Bruck W, Gleich G, R ansohoff RM, et al. A role for humoral mechanisms in the pathogenesis of Devic’s neuromyelitis optica. Brain [Internet]. 2002;125(Pt 7):1450-61. Disponibl en: http://linkinghub.elsevier.com/retrieve/pii/S0002939402017865.
Bourre B, Marignier R , Zéphir H, Papeix C, Brassat D, Castelnovo G, et al. Neuromyelitis optica and pregnancy. Neurology. 2012 Mar;78(12):875-9.
Wingerchuk DM, Lennon V a, Lucchinetti CF, Pittock SJ, Weinshenker BG. The spectrum of neuromyelitis optica. Lancet Neurology [Internet]. 2007 Sep;6(9):805-15. Disponibl en: http://www.ncbi.nlm.nih.gov/pubmed/23623397.
Collongues N, Marignier R , Zéphir H, Papeix C, Blanc F, R itleng C, et al. Neuromyelitis optica in France: a multicenter study of 125 patients. Neurology. 2010;74(9):736-42.
Pellkofer HL, Suessmair C, Schulze A, Hohlfeld R , Kuempfel T. Course of neuromyelitis optica during inadvertent pregnancy in a patient treated with rituximab. Mult Scler. 2009 Aug;15(8):1006-8.
Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG. R evised diagnostic criteria for neuromyelitis optica. Neurology. 2006 May;66(10):1485-9.
Filippi M, R occa MA, Moiola L, Martinelli V, Ghezzi A, Capra R , et al. MRI and magnetization transfer imaging changes in the brain and cervical cord of patients with Devic’s neuromyelitis optica. Neurology. 1999 Nov;53(8):1705-10.
Morlat P, Hocke C, Vergnes C, Ellie E, Viallard J, Faure I, et al. Case report Devic’s neuromyelitis optica during pregnancy in a patient with systemic lupus erythematosus. Lupus. 1999;8(3):244-8.
Ratelade J, Verkman AS. Neuromyelitis optica: aquaporin-4 based pathogenesis mechanisms and new therapies. Int J Biochem Cell Biol. 2012 Sep;44(9):1519-30.
Bukhari W, Barnett MH, Prain K, Broadley SA. Molecular pathogenesis of neuromyelitis optica. Int J Mol Sci. 2012 Jan;13(10):12970-93.
Papadopoulos MC, Verkman AS. Aquaporin 4 and neuromyelitis optica. Lancet Neurology. 2012 Jun;11(6):535-44.
Orthmann-Murphy JL, Abrams CK, Scherer SS. Gap junctions couple astrocytes and oligodendrocytes. Journal of molecular neuroscience : MN. 2008 May;35(1):101-16.
Pula JH, Macdonald CJ. Current options for the treatment of optic neuritis. Clin Ophthalmol [Internet]. 2012 Jan;6:1211-23. Disponibl en: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3422147&tool=pmcentrez&rendertype=abstract.
Sellner J, Boggild M, Clanet M, Hintzen R Q, Illes Z, Montalban X, et al. EFNS guidelines on diagnosis and management of neuromyelitis optica. Eur J Neurol. [Internet]. 2010 Aug [cited 2013 Mar 3];17(8):1019-32. Disponibl en: http://www.ncbi.nlm.nih.gov/pubmed/20528913.
McCarthy A, Dineen J, McKenna P, Keogan M, Sheehan J, Lynch T, et al. Anti-NMDA receptor encephalitis with associated catatonia during pregnancy. J Neurol. 2012 Dec;259(12):2632-5.
Heggermont WA, Verhelst C, De Wilde K, De Paepe M, Lacquet F, Vonck A. A case of HELLP syndrome: an immuno-“ logical” approach. Acta Clin Belg. 2012;67(5):375-7.
This journal is registered under a Creative Commons Attribution 4.0 International Public License. Thus, this work may be reproduced, distributed, and publicly shared in digital format, as long as the names of the authors and Pontificia Universidad Javeriana are acknowledged. Others are allowed to quote, adapt, transform, auto-archive, republish, and create based on this material, for any purpose (even commercial ones), provided the authorship is duly acknowledged, a link to the original work is provided, and it is specified if changes have been made. Pontificia Universidad Javeriana does not hold the rights of published works and the authors are solely responsible for the contents of their works; they keep the moral, intellectual, privacy, and publicity rights.
Approving the intervention of the work (review, copy-editing, translation, layout) and the following outreach, are granted through an use license and not through an assignment of rights. This means the journal and Pontificia Universidad Javeriana cannot be held responsible for any ethical malpractice by the authors. As a consequence of the protection granted by the use license, the journal is not required to publish recantations or modify information already published, unless the errata stems from the editorial management process. Publishing contents in this journal does not generate royalties for contributors.